DEPARTMENT OF DEFENSE - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS

The list of Fiscal Year 2021 Scleroderma Research Program Translational Research Partnership Award applications recommended for funding is for informational purposes only. Identification on the list of applications recommended for funding is not intended to either confer a right to funding nor does it guarantee funding. The award of federal funds to support any of these applications is contingent upon successful negotiations and applicable federal policy.

Institution Principal Investigator
Columbia University Medical CenterElana Bernstein
University of PittsburghHarinder Singh
University of PittsburghRobert Lafyatis
University of Texas Health Science Center at HoustonShervin Assassi
University of Texas Health Science Center at HoustonWenjin Zheng

Last updated Thursday, May 26, 2022